Martin Wilson, General Counsel at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,592 shares at $3.00 ($5K) on 2025-08-19, disclosed to the SEC on 2025-08-20.
Open-market sale of $5k RCKT by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.07 | 1,004 | $3K | 63.6% |
| 2 | $3.00 | 588 | $2K | 36.4% |
| Total | $3.04 avg | 1,592 | $5K | 100% |
| Filing → |
| RCKT | SELL | 2026-08-17 | $12K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $2K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $12K | — | Filing → |